Advertisements

Naftin cream

Quick links to important sections

Naftin cream

Advertisements
Advertisements

Method of action: Anti-Inflammatory

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Naftin cream

Property Description
Active Ingredient Naftifine Hydrochloride
Form Topical Cream, Gel, or Solution
Pharmacological Class Allylamine Antifungal
Origin Synthetic
Action Type Fungicidal (primarily)

What Type of Medicine is Naftifine Hydrochloride?

Naftifine Hydrochloride is the single active ingredient in Naftin cream and is classified as a synthetic drug belonging to the allylamine antifungal family. This classification defines the drug's fundamental nature as a compound developed to counter fungal pathogens through its unique chemical structure. The substance is a synthetic allylamine derivative, which places it within a targeted class of antifungals distinct from older types.

Naftifine is clinically recognized for its efficacy against common dermal infections. The official labeling confirms that this medication is a synthetically derived allylamine used to eliminate fungal organisms. This precise classification ensures the drug is primarily effective as a broad-spectrum agent, offering a specific approach against a wide variety of common pathogenic fungi.

Understanding Naftin's Form and General Purpose

The medication is formulated for topical application onto the skin and is available in multiple high-level dosage forms, including a cream, gel, and solution. The topical cream utilizes an emulsified base, providing a delivery vehicle that aids the skin penetration of Naftifine Hydrochloride to reach the site of infection. The drug's mechanism involves the inhibition of the synthesis of a vital component of the fungal cell wall. This mechanism allows the drug to effectively stop the fungal infection at its source.

The general purpose of this topical antifungal is the clearance or elimination of fungal infections; the selection of its topical form is primarily determined by the nature and location of the infected skin area, maximizing the local concentration of the active ingredient.

Key Difference: Is Naftifine Fungistatic or Fungicidal?

As a member of the allylamine family, Naftifine is primarily characterized as having fungicidal properties, which means it actively kills the fungal organisms rather than only slowing their growth (fungistatic action). This robust, definitive action against the pathogen is a key distinguishing feature of its pharmacological class. This active elimination defines the therapeutic intent of the Naftifine Hydrochloride compound against dermal pathogens.

Regulatory References

  1. Naftifine Hydrochloride Cream Label
Advertisements

What side effects are possible with Naftin cream?

Possible Side Effects and Safety Information

The safety profile for Naftifine Hydrochloride topical formulations is primarily characterized by adverse reactions occurring at the site of application, as documented in official regulatory labeling. These reactions are officially classified as common based on clinical trial data.

Common Adverse Reactions

The most frequent adverse reactions reported during clinical trials for Naftin cream and gel include:

  • Pruritus (itching): The single most common reaction reported.
  • Burning and Stinging: Often experienced immediately upon application.
  • Local Irritation, Erythema (redness), and Dryness.

These effects are generally local and confined to the area of treatment. If irritation or signs of sensitivity develop, the official regulatory labeling states that treatment should be discontinued.


Serious and Systemic Safety Considerations

Postmarketing surveillance has identified rare reports of systemic adverse reactions that are considered serious, although their frequency is not reliably established. These include leukopenia and agranulocytosis (severe decreases in white blood cell count), as well as nervous system effects such as headache and dizziness. The medication is contraindicated in individuals with a known hypersensitivity to Naftifine or any component of the formulation.


Population-Specific Safety Notes

  • Pregnancy and Lactation: There are no adequate and well-controlled studies in pregnant women. Use during pregnancy is advised only if the potential benefit outweighs the risk to the fetus. It is unknown if the drug is excreted in human milk, thus caution is advised for nursing mothers.
  • Pediatric Use: Safety and effectiveness are established for specific age ranges depending on the fungal infection treated. Safety has not been established in pediatric patients younger than the ages specified in the official labeling. The product is for topical use only and must not be used in the eyes (ophthalmic use).
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Naftifine Hydrochloride topical formulations establishes that systemic overdosage is considered unlikely to occur with routine topical application of the cream. This determination is based on the drug’s characteristic of low systemic absorption through the skin, which significantly limits the potential for toxic systemic concentrations when used as intended.

The regulatory focus for overdose risk pertains primarily to the scenario of accidental ingestion of the topical product. When this type of non-topical exposure is suspected or known, the guidance on when to seek urgent medical attention is explicitly defined.

Emergency Actions Mandated by Regulators

If accidental ingestion of the cream has occurred, it is a mandatory requirement to seek immediate medical attention. This instruction is the explicit, label-derived direction for emergency response, indicating the need for official assessment following ingestion.

Official Management and Treatment

The officially documented management strategy for overdose, particularly following ingestion, is limited to providing symptomatic and supportive treatment. Regulatory documents confirm that no specific antidote is known or listed for Naftifine Hydrochloride overdose. Beyond the risk associated with ingestion, official labeling does not document any specific, severe systemic symptom clusters or population-specific overdose considerations.

Advertisements

Therapeutic Uses of Naftin cream

What Naftin Cream Treats: Main Uses and Benefits

This medication is generally used to treat fungal skin infections known as tinea, including Tinea pedis (athlete's foot), Tinea cruris (jock itch), and Tinea corporis (ringworm of the body). It is relevant for easing symptom clusters that characterize active tinea, which commonly involves intense itching (pruritus), a localized burning sensation, skin redness (erythema), and physical breakdown like scaling and cracking.

The medication is used for managing the causative fungal organisms and is applied during acute symptomatic episodes, particularly in moisture-prone areas like between the toes (interdigital tinea pedis) and skin folds. Applied in situations where additional management of discomfort is required, it contributes to managing the fungal load and may assist with addressing symptoms related to inflammatory or irritative states.

By supporting clearance, the treatment contributes to improved day-to-day comfort and assists with maintaining functional stability.


Quick Fact: Relief for Pruritus and Inflammation Naftin cream is considered relevant for easing symptoms related to inflammatory or irritative states caused by fungal activity, helping to address the overall symptom burden.

Regulatory References

  1. FDA DailyMed labeling overview
Advertisements

Eligibility and Restrictions for Use

The eligibility profile for using Naftin cream (naftifine hydrochloride) is strictly defined by regulatory labeling, outlining which populations are permitted or restricted from using the medicine.

Absolute Contraindication

The medication is absolutely prohibited for use in any individual with a known hypersensitivity or allergy to naftifine hydrochloride or any other component listed in the product formulation.

Age-Related Eligibility Rules

Use of the topical cream is generally established for adults and adolescents 12 years of age and older. For the treatment of tinea corporis, use is established for children 2 years of age and older. However, safety and effectiveness have not been established in pediatric patients younger than 12 for tinea pedis and tinea cruris, nor in children younger than 2 for tinea corporis.

Pregnancy and Lactation Status

For pregnant women, Naftin cream should be used only if clearly needed, as adequate human studies are unavailable. Caution should be exercised when administering the cream to nursing women, due to a lack of information regarding the excretion of the drug into human milk. No systemic eligibility restrictions are explicitly listed in the label based on hepatic or renal impairment.

Advertisements

What should I know about interactions with other medicines?

Naftin cream (naftifine hydrochloride) is a topical antifungal medicine, and its interaction profile is generally considered minimal because the amount of medication absorbed into the bloodstream after skin application is very low (systemic absorption is approximately 4% to 6% of the applied dose).

Authoritative medical and regulatory sources, such as the U.S. Food and Drug Administration (FDA), do not typically include a dedicated drug-drug interaction section in the labeling for Naftin cream. This signifies that no formal, clinically significant interactions with specific oral medicines, other medicinal products, or food are currently documented or expected.

Procedural Constraint Related to Absorption

The only procedural constraint noted in the official labeling relates to minimizing any potential increase in systemic exposure, which could theoretically affect interaction risk:

  • Occlusive Dressings: Avoid covering the treated skin area with bandages, dressings, or wrappings that do not allow air circulation unless specifically instructed to do so by a healthcare professional. Such coverings may increase the amount of medicine absorbed through the skin.
Advertisements

Mechanism of Action

How Naftin Cream Works

Naftifine hydrochloride exerts its primary action through a targeted enzyme inhibition within the fungal organism. The molecule binds to and blocks Squalene Epoxidase (SQLE), a key enzyme in the fungal cell's metabolic pathway. This specific blockade prevents the synthesis of ergosterol, a sterol molecule essential for maintaining the structural integrity and fluidity of the fungal plasma membrane.

Inhibition of SQLE triggers a dual molecular cascade: the crucial product, ergosterol, becomes depleted, while the substrate molecule, squalene, accumulates to toxic intracellular concentrations. This combination of membrane instability and cytotoxicity produces an irreversible physiological consequence: the structural breakdown and subsequent death of the fungal cell, resulting in fungicidal action.

Independent of this anti-fungal action, the naftifine molecule also exerts a modulatory effect on local host tissue processes. This secondary mechanism involves influencing peripheral immune pathways, which contributes to the dampening of excessive signaling from inflammatory mediators and influencing the tissue's overall response profile.

Advertisements

Dosage and Administration Information

How to Use Naftin Cream: Official Administration Guidelines

The usage protocol for Naftin (naftifine hydrochloride) is established for the topical route of administration. The medication is for application to the skin and is specifically not for ophthalmic, oral, or intravaginal use.

Labeled Dosing and Scheduling

The frequency and total duration of the treatment course depend on the specific formulation being administered. The standard adult dosing regimen requires the application of a thin layer or sufficient quantity gently massaged into the affected skin and the surrounding area.

Formulation Standard Frequency Course Duration Application Rule
1% Cream/Gel Once daily (qDay) / Twice daily (BID) for 1% Gel 4 weeks Apply to affected and surrounding skin
2% Cream/Gel Once daily (qDay) 2 weeks Apply to affected area plus a ½ inch margin of healthy surrounding skin

Procedural Constraints and Special Rules

Administration involves procedural constraints designed to ensure proper delivery of the active ingredient. Instructions include the requirement to wash hands after application. Furthermore, the administration guidelines advise against the use of occlusive dressings or wrappings over the application site unless specifically instructed otherwise. The duration of therapy is fixed at either 2 or 4 weeks; if no clinical improvement is observed after the specified course duration, the treatment must be re-evaluated. Age-specific rules indicate that the 2% formulation, used once daily for 2 weeks, is supported for administration in pediatric patients 12 years of age and older.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Naftin Cream

Evidence for Use in Tinea Pedis (Athlete's Foot)

Research exploring Naftin cream for athlete's foot (tinea pedis) has primarily involved short-term Randomized Controlled Trials (RCTs). These studies were designed to evaluate various types of change, including the measured clearance for the infection, which is defined as both the disappearance of physical symptoms and the measured clearance of the fungus (mycological cure). Studies examined changes in symptom measurements in adult and adolescent populations who were observed to have the condition.

Evidence for Use in Tinea Cruris (Jock Itch)

For jock itch (tinea cruris), the evidence largely comes from short-term vehicle-controlled trials and other research that explored changes measured during the study period. These trials monitored outcomes related to physical discomfort and the measurement of changes related to the fungal infection in adults and adolescents. Studies reported measurements of complete cure (fungus clearance combined with symptom resolution) at defined time points, usually around two weeks after the treatment ended.

Evidence for Use in Tinea Corporis (Ringworm of the Body)

Naftin cream was studied for ringworm (tinea corporis) through various clinical research, including trials specifically conducted in pediatric age groups. Studies monitored outcomes related to physical discomfort, such as itching and redness, and also tracked the measurement of clearance for the infection in both adults and children aged 2 years and older. The studies report how symptoms evolved in the observed populations, providing context for the measured rates of mycological and clinical clearance in patients across the included age ranges.

What is Still Uncertain About Naftin Cream

Key uncertainties exist regarding the long-term status of a treated infection, as follow-up durations were limited and research on long-term effects is not fully established. Comparative evidence against every available antifungal is lacking. Furthermore, the extent to which study results apply to very small children (under 2 years) or individuals with significant systemic comorbidities is not well characterized. Understanding these various scenarios requires further research.

Key Studies & References

  1. Label: NAFTIFINE HYDROCHLORIDE cream (2%) – Clinical Studies (Tinea Pedis, Tinea Cruris, Tinea Corporis) and Pediatric Use
  2. Label: NAFTIFINE HYDROCHLORIDE cream (1%) – Clinical Studies and Indications
  3. FDA Pediatric Research Equity Act (PREA) Review for Naftifine (Pediatric Safety and Efficacy)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Naftin cream (FAQ)


Q: What is Naftin cream used for?

Naftin cream is an anti-fungal medication. According to official product information, it is indicated for the topical treatment (application to the skin) of specific superficial fungal infections, such as Tinea pedis (athlete's foot), Tinea cruris (jock itch), and Tinea corporis (ringworm) caused by certain susceptible organisms.


Q: Is Naftin cream available over the counter?

Regulatory documents state that Naftin cream requires a prescription from a healthcare provider. It is not an over-the-counter (OTC) medicine, meaning it must be dispensed by a pharmacy based on a valid prescription.


Q: What happens if I miss a dose of Naftin cream?

Official product information for Naftin cream indicates the standard procedure for a missed dose is to apply it as soon as the patient remembers. If it is close to the time for the next scheduled application, the missed dose is typically skipped, and the regular schedule is resumed. Regulatory documents advise against using extra cream to compensate for a missed dose.


Q: How should I store Naftin cream?

Official product labeling specifies that Naftin cream should be stored at room temperature, which is considered 20 C to 25 C (68 F to 77 F). Regulatory labeling specifies that the product should be kept out of the reach of children and that freezing the cream must be avoided.


Q: Is Naftin cream safe to use during pregnancy?

Regulatory documents indicate that there are no adequate and well-controlled studies of Naftin cream in pregnant women. Regulatory documents state that use during pregnancy should only occur if the potential benefit warrants the potential risk to the fetus. This determination is made by a prescribing healthcare provider, given the lack of adequate human studies.


Q: Can children use Naftin cream?

The official product information states that the safety and effectiveness of Naftin cream have not been established in children under the age of 12. Because safety and effectiveness are not established in this age group, use would require the guidance of a qualified healthcare provider.


Q: Can Naftin cream cause skin irritation or redness?

Official product information and studies list some common side effects. The most frequently reported localized adverse reactions are burning/stinging, irritation, redness (erythema), and itching (pruritus) at the site of application. These reactions are typically mild and localized.

Advertisements

How should Naftin cream be stored and disposed of?

How to Store and Dispose of Naftin Cream

The storage and disposal requirements for Naftin cream are defined by official regulatory guidelines to ensure stability and safety.

Storage Conditions:

Requirement Official Standard
Temperature Store at 25 C (77 F); excursions permitted to 15 C–30 C (59 F–86 F)
Handling Keep in the original container, tightly closed. Keep from freezing.
Safety Store out of the reach of children.

To dispose of unused or expired Naftin cream, do not keep the medicine or use it past its expiration date. Official guidance instructs patients to consult a healthcare professional regarding the appropriate method for final disposal of any unused product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Naftin cream found in:

A-Z Index: